Isosorbide oral liquid for Meniere's disease
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial tests an oral liquid medication called isosorbide to see if it can reduce vertigo episodes in people with Meniere's disease. The study will compare its effects against a placebo to confirm if it's safe and helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 65 years old.
- You must have Meniere's disease affecting only one ear, confirmed by a doctor.
- You must have had at least 3 episodes of vertigo (spinning dizziness) in the last 6 months.
- You cannot have had ear surgery for Meniere's disease in the past.
- You must be willing to avoid certain medications (like diuretics, antihistamines, or steroids) during the trial.
- You must not be pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study compares injections of steroid medicine into the ear versus a dummy (placebo) injection to see if it reduces vertigo attacks in people with Ménière’s disease. It may help by improving balance symptoms and reducing how often attacks happen.
This Phase 4 study tests whether migraine-type medications can help people with active or frequent Meniere’s disease. If you have symptoms like inner-ear episodes, the trial may help find a better way to control them.
This research study investigates the genetic and biological factors that cause Menière's disease—a condition affecting the inner ear that causes dizziness, hearing loss, and ear fullness. By studying these factors, researchers hope to better understand why some patients experience different symptoms and potentially improve future treatments.
This trial tests a new medication called Vespireit (prolonged-release buspirone) for people with chronic dizziness caused by a problem with the autonomic nervous system. The study aims to see if the drug helps reduce dizziness and improve quality of life.
This study is testing a device that may help reduce motion sickness and feelings of disorientation. Healthy people who do not usually get motion sickness are needed to participate.
This trial tests if the drug Northera (droxidopa) can help children with Menkes disease who have dizziness when standing or chronic diarrhea. It aims to improve these symptoms by supporting blood pressure and bowel function.
Hear when a new Meniere´s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.